In conclusion, both RYGB and SG induce a significant increase in HDL and ApoA1, and a decrease in LDL, oxLDL and ApoB, in women with severe obesity and a high cardiovascular risk defined by the presence of the metabolic syndrome. Here, APOB is linked to obesity disorder.